Solana (SOL) saw a significant 46% price increase in August, ending a ten-month decline and reaching its highest point since January. This surge is attributed to substantial institutional investment, with US spot Solana ETFs accumulating $1.34 billion in inflows, and major players like Charles Schwab planning to offer SOL trading. Additionally, network enhancements such as the "Double Disinflation" governance proposal, which slows SOL issuance, and the upcoming Transaction V1 upgrade, which increases transaction capacity, are contributing to positive market sentiment.
Amgen's Repatha (evolocumab) significantly reduced all-cause and cardiovascular death risk by 20% in over 12,000 high-risk patients without previous heart attack or stroke, according to the Phase 3 VESALIUS-CV trial. The benefit emerged after 1.5 yea...
Binance Coin (BNB) surged above $700 in late August, gaining 18% in a week amid bullish market sentiment and strong trading volume. Technical analysts highlight $725 as a key resistance level; breaking it could trigger more buying, while support lies...
Defence Therapeutics, a biotechnology company, is expanding its radiopharmaceutical development program to include both alpha and beta-emitting radioisotopes. This move aims to broaden the capabilities of its proprietary Accum® technology, which is d...
Bitcoin traded near $77,900 on Aug. 31, showing resilience despite renewed US-Iran conflict that pushed oil prices above $90 and pressured global stocks. BTC gained about 23% in August, outperforming gold and Nasdaq. The Federal Reserve's hawkish sta...
U.S. small-cap equities showed robust gains in the second quarter of 2026, with the Russell 2000 Growth Index up 25.71%, outperforming the Russell 2000 Value Index's 17.19% increase. The Harbor Human Capital Factor US Small Cap ETF returned 20.45% du...
